Every multicellular organism depends on a controlled form of cellular suicide called apoptosis. The central executioners of this process are caspases โ Cysteine-dependent Aspartate-specific proteases. These enzymes use an active-site cysteine to cut target proteins specifically after aspartate residues. The cell does not produce caspases in their active form. It produces them as inactive precursors called procaspases. A genuine death signal activates them only when required.
1. Structure of Caspases
A) The Inactive Form: Procaspase
Every caspase is first synthesized as an inactive precursor called a procaspase. This inactive form is also referred to as a zymogen. The cell deliberately produces caspases in this inactive state to prevent accidental activation and unintended cell death. Each procaspase is a single, continuous polypeptide chain. Despite differences in size and function across caspase family members, all procaspases share the same conserved domain organization from N-terminus to C-terminus:
Prodomain โ Large subunit (p20) โ Small subunit (p10)
These three regions are encoded in one chain, connected by short interdomain linker sequences. The procaspase remains inactive as long as this chain is intact and the prodomain is in place. Activation requires proteolytic cleavage at specific aspartate residues within these linker regions, which separates the domains and triggers reassembly into the active form.
a) Prodomain
- Length varies:
- Long prodomain (80โ200 aa) in initiator caspases โ contains proteinโinteraction motifs (DED or CARD).
- Short prodomain (20โ30 aa) in executioner caspases.
- Function: keeps the caspase inactive; helps recruit procaspases to activation platforms.
b) Large subunit (p20, ~20 kDa)
- Contains the catalytic cysteine (Cys) in a conserved QACXG motif (where X is any amino acid).
- Forms one half of the active site.
c) Small subunit (p10, ~10 kDa)
- Contributes to substrate binding.
- Together with p20, completes the active site.
B) Active caspase structure
After activation, the prodomain is removed. Two p20 and two p10 subunits then assemble into a heterotetramer: (p20โp10)โ. Each catalytic site forms at the interface between the p20 of one heterodimer and the p10 of the other.
| Domain | Detail | Role |
|---|---|---|
| N-terminal Prodomain | Long (initiators) or short (executioners) | Keeps the enzyme inactive; recruits it to activation platforms via DED or CARD motifs |
| Large subunit (p20) | ~20 kDa | Carries the catalytic Cys-285 โ the actual cutting residue |
| Small subunit (p10) | ~10 kDa | Completes the active site geometry; essential for substrate recognition |
The prodomain acts as a molecular safety lock. As long as it is attached, the caspase cannot function.
C) The Active Form: Heterotetramer
When an apoptotic signal arrives, the prodomain is cleaved off. The p20 and p10 subunits separate and then reassemble into a heterodimer. Two such heterodimers come together to form the active caspase:
Active caspase = (p20 + p10) + (p20 + p10) = Heterotetramer with 2 active sites
Both active sites function simultaneously. The catalytic Cys-285, assisted by His-237, attacks the substrate peptide bond directly on the C-terminal side of an aspartate residue. The substrate aspartate is held in position by the S1 pocket of the enzyme.
(Diagram to draw: Procaspase โ proteolytic cleavage โ p20 + p10 heterodimer โ two heterodimers assemble โ active heterotetramer with two active sites)
2. Classification of Caspases
Caspases are not all the same. They are divided into two functional groups based on their prodomain length, recruitment mechanism, and role in apoptosis.
A. Initiator Caspases โ The Signal Receivers
These caspases sit at the top of the cascade. They are the first to respond to a death signal.
| Caspase | Prodomain Motif | Where They Are Activated |
|---|---|---|
| Caspase-8, -10 | DED (Death Effector Domain) | DISC โ Extrinsic pathway |
| Caspase-9 | CARD (Caspase Activation and Recruitment Domain) | Apoptosome โ Intrinsic pathway |
Their prodomain is long and carries either a DED or CARD motif. This motif is not a structural decoration โ it is the key that allows the caspase to dock onto specific protein platforms.
How Do Initiator Caspases Activate?
Initiator caspases exist as inactive monomers in the cytoplasm. A death signal recruits them to a protein platform โ either the DISC or the apoptosome โ through DED:DED or CARD:CARD interactions. The platform brings many procaspase molecules into close proximity. Proximity forces them to dimerize. Dimerization triggers a conformational change that generates an active catalytic site.
The critical point: no proteolytic cleavage is needed. Proximity-induced dimerization alone is sufficient to activate initiator caspases.
B. Executioner Caspases โ The Cell Killers
These caspases do the actual destructive work inside the cell.
- Examples: Caspase-3, -6, -7
- Their prodomain is short and carries no DED or CARD motif.
- They exist in the cytoplasm as inactive dimers โ already paired up but not yet active.
How do they activate? They cannot activate themselves. They wait until an initiator caspase cleaves them at the inter-domain linker between p20 and p10. This proteolytic cleavage forces the subunits to rearrange into the active heterotetramer conformation. No platform is needed โ the cleavage happens directly in the cytoplasm.
This is the critical distinction: initiators activate by dimerization; executioners activate by cleavage.
C. Inflammatory Caspases โ A Note for Context
Caspase-1, -4, -5 (human) and caspase-11 (mouse) are inflammatory caspases. They drive pyroptosis โ an inflammatory form of cell death โ and process IL-1ฮฒ. They are not apoptotic caspases and do not participate in the apoptotic cascade. Do not place them in the executioner group. This is a common exam error.
Summary Table
| Feature | Initiator | Executioner |
|---|---|---|
| Examples | Caspase-8, -9, -10 | Caspase-3, -6, -7 |
| Prodomain | Long | Short |
| Motif | DED (8,10) / CARD (9) | None |
| Resting state | Inactive monomer | Inactive dimer |
| Activation | Proximity-induced dimerization | Proteolytic cleavage by initiators |
| Platform needed | Yes (DISC or Apoptosome) | No |
3. Activation Pathways
A. Extrinsic Pathway โ Caspase-8 at the DISC
Death ligands trigger the extrinsic pathway by binding to death receptors on the cell surface. FasL binds Fas. TNF-ฮฑ binds TNFR1. TRAIL binds DR4 or DR5.
Ligand binding clusters the receptors together. The clustered receptors recruit the adaptor protein FADD through Death Domain (DD) interactions. FADD then recruits multiple procaspase-8 molecules through its DED domain. This three-component assembly โ death receptor, FADD, and procaspase-8 โ forms the DISC (Death-Inducing Signaling Complex).
The DISC forces procaspase-8 molecules into close proximity. Proximity drives dimerization. Dimerization activates caspase-8. Active caspase-8 then cleaves procaspase-3 and launches the executioner phase.
B. Intrinsic Pathway โ Caspase-9 at the Apoptosome
Intracellular stress signals trigger the intrinsic pathway. DNA damage, oxidative stress, and growth factor withdrawal all activate the pro-apoptotic proteins BAX and BAK.
BAX and BAK permeabilize the mitochondrial outer membrane โ a process called MOMP (Mitochondrial Outer Membrane Permeabilization). MOMP releases cytochrome c from the mitochondrial intermembrane space into the cytoplasm.
In the cytoplasm, cytochrome c binds Apaf-1 in the presence of dATP. This binding triggers a conformational change in Apaf-1. Seven activated Apaf-1 molecules then oligomerize into the apoptosome โ a heptameric, wheel-shaped platform.
The CARD domain of Apaf-1 recruits procaspase-9 through CARD:CARD interaction. The apoptosome forces procaspase-9 molecules into proximity, activating caspase-9. Active caspase-9 then cleaves procaspase-3 and procaspase-7, activating the executioner caspases and committing the cell to apoptosis.
C. What Active Caspase-3 Actually Does
Once active, caspase-3 dismantles the cell by cutting specific structural and regulatory proteins:
| Substrate | What Happens After Cleavage |
|---|---|
| PARP-1 | DNA repair enzyme is permanently inactivated โ the cell can no longer fix its own DNA |
| Lamin A/B | Nuclear lamina collapses โ nuclear condensation and fragmentation |
| ICAD | Releases CAD (Caspase-Activated DNase) โ CAD cleaves DNA between nucleosomes โ produces the classic 180 bp DNA ladder on agarose gel |
| Gelsolin | Truncated active form disrupts the actin cytoskeleton |
| Cytoskeletal proteins | Cell shrinks and forms membrane blebs |
The 180 bp internucleosomal DNA ladder seen on agarose gel is the biochemical signature of apoptosis and is a direct consequence of caspase-3 cleaving ICAD.
4. Regulation of Caspases
A cell cannot allow caspases to fire at random. Several regulatory proteins act as checks and balances.
IAPs (Inhibitors of Apoptosis Proteins) are the primary brake. XIAP, the best-characterized IAP, binds directly to caspase-3, -7, and -9 through its BIR (Baculoviral IAP Repeat) domain and physically blocks their active sites. BIR2 targets caspase-3 and -7; BIR3 targets caspase-9.
Smac/DIABLO is the counter to IAPs. It is released from the mitochondria during MOMP, alongside cytochrome c. Its IBM (IAP-Binding Motif) allows it to bind IAPs and displace the caspases they were holding. Once released, caspases are free to proceed.
IAPs suppress caspases at rest. Smac removes that suppression when apoptosis must happen. Together they form a molecular on/off switch.
FLIP operates at the DISC level. It is structurally similar to caspase-8 but lacks the catalytic cysteine โ it is enzymatically dead. FLIP competes with procaspase-8 for FADD binding at the DISC. If FLIP wins the competition, caspase-8 cannot dimerize and the extrinsic pathway is blocked.
p53, activated by DNA damage, transcriptionally upregulates BAX, PUMA, NOXA, and Apaf-1 โ all of which push the cell toward MOMP and apoptosome formation, amplifying the intrinsic pathway.
Bcl-2 family proteins control MOMP itself. Anti-apoptotic members (Bcl-2, Bcl-xL) prevent MOMP and therefore block cytochrome c release and apoptosome assembly. Pro-apoptotic members (BAX, BAK, BID) promote MOMP and drive the intrinsic cascade forward.
5. Experimental Tool: Z-VAD-FMK
Z-VAD-FMK is a synthetic, cell-permeable, irreversible pan-caspase inhibitor. It covalently modifies the catalytic cysteine of all caspases, blocking their activity completely. In experimental settings, if Z-VAD-FMK treatment abolishes cell death, the conclusion is that the death was caspase-dependent apoptosis. It is the standard pharmacological tool used to confirm caspase involvement in any death pathway.
Conclusion
Caspases execute apoptosis with precision and order. The cell produces them as inactive procaspases and activates them through two distinct mechanisms โ proximity-induced dimerization activates initiator caspases, and proteolytic cleavage activates executioner caspases. The IAP/Smac system, FLIP, and the Bcl-2 family together regulate and balance this activity.
When this balance breaks down, disease follows. Insufficient caspase activity allows damaged or autoreactive cells to survive, driving cancer and autoimmunity. Excessive caspase activation kills cells that should survive, contributing to neurodegeneration and ischemic injury.
Understanding the caspase cascade is therefore essential โ not only for cell biology, but also for designing targeted therapies that restore this balance in disease.
Summary Table
| Feature | Detail |
|---|---|
| Inactive form | Procaspase โ single polypeptide |
| Domain order | Prodomain โ p20 โ p10 |
| Initiator prodomain | 80โ200 aa; DED or CARD |
| Executioner prodomain | 20โ30 aa; no motif |
| Catalytic motif | QACXG in p20; C = Cys-285 |
| Catalytic dyad | Cys-285 + His-237 |
| Substrate recognition | S1 pocket in p10; P1 = Asp |
| Active form | (p20โp10)โ heterotetramer |
| Active sites | Two; at inter-heterodimer interface |
Key Exam Points
- Procaspase = zymogen = single chain = inactive.
- Domain order: Prodomain โ p20 โ p10.
- Initiator caspases: long prodomain + DED or CARD. Executioner caspases: short prodomain, no motif.
- QACXG motif = conserved signature; C = Cys-285.
- Catalytic dyad = Cys-285 + His-237.
- Active form = (p20โp10)โ = two active sites.
- Active site = interface between p20 of one heterodimer + p10 of the other.
- Single heterodimer = inactive. Tetramer = minimum active unit.
- Caspases cleave only after aspartate at P1.
- DED and CARD are homotypic โ each binds only its own type.
Common Mistakes โ Do Not Make These
| Wrong Statement | Correct Version |
|---|---|
| โCaspases are serine proteasesโ | They are cysteine proteases โ Cys-285 is the catalytic residue |
| โCaspase-9 is an executionerโ | Caspase-9 is an initiator of the intrinsic pathway |
| โCARD is for caspase-8; DED is for caspase-9โ | CARD โ caspase-9; DED โ caspase-8 and -10 |
| Skipping heterotetramer structure | Always write: active caspase = (p20โp10)โ with two active sites |
| โInitiator caspases are cleaved to activateโ | Initiators activate by dimerization only โ cleavage is not required |